[1]
Ezwaie, M. et al. 2024. Prevalence and risk factors of erythropoiesis stimulating agents hyporesponsiveness in chronic hemodialysis patients attending nephrology center of Benghazi. Libyan Journal of Medical Research. 18, 1 (Jan. 2024), 112–128. DOI:https://doi.org/10.54361/LJM18.12.